Furthermore, ApoJ may act in conjunction with other genetic risk factors, such as ApoE, and this in turn may play a role in the development and progression of post-ischemic neurodegeneration and Alzheimer’s disease [97]. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.